Introduction
Events that give rise to PTSD typically involve interpersonal violence (e.g. rape, assault, hijacking) or exposure to life-threatening accidents (e.g. motor vehicle accidents) or disasters (e.g. fires, floods). These events are characterised by their capacity to evoke fear, helplessness, or horror in response to the threat of injury or death. Although PTSD has been studied most rigorously in combat veterans, the type of trauma most likely to provoke PTSD is assaultive violence, particularly rape, which contributes to the high prevalence of the disorder in women (women are twice as likely to develop PTSD as men). Of note, the vast majority of survivors of trauma do not develop PTSD. In fact, epidemiological studies indicate that while 40-90% of the general population are exposed to a traumatic event in their lifetime, only 1-9% develop PTSD. The following factors may make it more likely that a person will develop PTSD: (i) the more severe and long-lasting the trauma, (ii) the closer the person was to it, (iii) the more dangerous it seemed, (iv) the more times the person has been traumatised, and (v) negative reactions from relatives and friends.
The Posttraumatic stress disorder (PTSD) is a serious and disabling disorder that is commonly seen in primary care settings. Primary care practitioners can be instrumental in recognising, diagnosing, and treating PTSD. Unless trauma histories are specifically obtained, the disorder is easily missed because of the substantial symptom overlap with depression and other anxiety disorders, the significant medical and psychiatric comorbidity, and the stigma, shame and secrecy that are often associated with the diagnosis.
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to do so. If psychotherapy is not an option, the clinician should offer the patient medication from the beginning. Medication should also be prescribed to patients who prefer medication, whose symptoms are severe and persistent, who have comorbid depression or anxiety, or whose daily functioning is severely disrupted.
Medications
The selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and monoamine oxidase inhibitors have been shown in randomised clinical trials to be effective in treating PTSD symptoms and improving the quality of life of these patients. SSRIs should be considered as a first-line option because they are safer and better tolerated than the older antidepressants. They are also effective in treating associated anxiety or depression. 
Psychotherapy
Three specialised types of psychotherapy, used alone or in combination with medication, are effective in helping patients confront their fears by reducing psychological and physiological distress associated with memories of the traumatic event: (i) exposure therapy -helping patients confront the specific situations that remind them of their terrifying experience (e.g. driving a car again after being involved in an accident). Repeated exposures helps the patient to realise that the feared situation is no longer dangerous and they can handle it, (ii) cognitive therapyhelping patients change irrational beliefs, e.g. unrealistic guilt, and (iii) anxiety management -teaching patients skills such as relaxation training and positive thinking. Group therapy may also be helpful in some patients in reducing isolation. Primary care physicians may themselves be able to provide psychotherapy or may wish to refer to a clinician with expertise in this area.
See CPD Questionnaire p.47
